PARP1 and neoplasm: The treatment with these two KMT inhibitors caused an increase in DNA damage, higher when cells were treated with IR or doxorubicin, which was detected by labelling of free DNA-ends in TUNEL assays, and an increase in processed PARP1 and caspase-3, which indicates that apoptosis has been activated in tumor cells.